Unitaid Invested $36 Million in Malaria Prevention Programs
New research projects will test the real-world efficacy of spatial emanators and insecticide-treated baby wraps.
Updated on Sept. 28, 2026 in COVID-19
Live Poll
Should international health organizations prioritize funding for new technological interventions in malaria control?
Unitaid has committed $36 million toward two programs evaluating innovative malaria prevention technologies. These initiatives aim to determine if tools previously shown to be successful in controlled trials maintain their effectiveness in diverse, real-world environments.
Why it matters
Traditional malaria control methods are losing efficacy due to rising insecticide resistance and evolving mosquito behaviors. This funding seeks to bridge the gap between clinical trial results and real-world implementation, potentially shaping future public health strategies.
A prior Kenyan trial recorded a 32% reduction in malaria infections using spatial emanators, while an Ugandan study showed a 66% drop in infant cases with insecticide-treated baby wraps. These results prompted the WHO to issue a conditional recommendation in 2025.
The players
Unitaid
Unitaid is an international organization that invests in new ways to prevent, diagnose, and treat diseases in low- and middle-income countries.
World Health Organization
The World Health Organization is the United Nations specialized agency responsible for international public health.
Swiss Tropical and Public Health Institute
This institute is a public institution associated with the University of Basel that focuses on global health research and education.
Centre for Research in Infectious Diseases
The Centre for Research in Infectious Diseases is a research organization that investigates major health threats including malaria and other vector-borne illnesses.
The details
The Swiss Tropical and Public Health Institute and the Centre for Research in Infectious Diseases are spearheading the research across Cameroon, Kenya, and the Myanmar border. The studies will evaluate community acceptance, integration into current programs, and the performance of spatial emanators against varied mosquito populations.
Timeline
The World Health Organization issued a conditional recommendation for spatial emanators in 2025.
A target has been set to reach 60 million people with spatial emanators by 2029.
Health Landscape
This investment follows and operationalizes the World Health Organization's 2025 conditional recommendation by funding the necessary real-world evidence gathering. The initiative represents a critical shift toward validating scalable technologies that can bypass the limitations of current insecticide-based protocols.
The study aims to integrate these technologies into existing local programs, potentially offering new, simple preventive measures for families in high-transmission areas. Increased access to these tools could significantly lower infant mortality rates and reduce the burden of frequent clinical treatment.
The takeaway
These programs focus on adapting advanced technologies for everyday household use rather than relying solely on clinical interventions. Families and health providers in affected regions may eventually have access to more durable and effective preventive tools as research progresses.
Further reading
For broader context on international disease control efforts, visit the COVID-19 section.
Source note: This article includes information reported by Social TV.
Live Poll
Should international health organizations prioritize funding for new technological interventions in malaria control?
